Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 13 EP applications Bernd Liphardt has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12788585

ARYL DERIVATIVES FOR CONTROLLING ECTOPARASITES

IPC classification:
A61K 31/42, A61P 33/00
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP12707629

ISOXAZOLE DERIVATIVES

IPC classification:
A01N 43/80, A01N 47/38, C07D 413/04, C07D 413/14, C07D 417/14, C07D 419/04
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13704563

SYSTEM FOR PROVIDING A LIQUID-SUBSTANCE MIXTURE ATTRACTIVE TO AN ANIMAL

IPC classification:
B65D 51/28, B65D 81/32
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13721733

TREATMENT OF FISH POPULATIONS WITH LUFENURON

IPC classification:
A01N 47/34, A61K 31/17, A61P 33/14
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13739444

NEW TREATMENT OF FISH WITH A NANOSUS PENS ION OF LUFENURON OR HEXAFLUMURON

IPC classification:
A01N 47/34, A61K 9/00, A61K 9/14, A61K 31/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13747376

SUBTITUTED AZINES AS PESTICIDES

IPC classification:
A01N 43/54, A01P 17/00, A61K 31/505, A61K 31/506, C07D 213/74, C07D 239/47, C07D 239/48, C07D 401/04, C07D 401/12, C07D 401/14, C07D 403/04, C07D 403/12, C07D 403/14, C07D 413/14, C07D 487/10
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
PATENT GRANTED
EP13799490

NEW TREATMENT

IPC classification:
A01N 51/00
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14162391

Aminosulfonylmethylcyclohexanes as JAK inhibitors

IPC classification:
A61K 31/44, A61K 31/50, A61K 31/505, A61K 31/52, C07D 239/46, C07D 471/04, C07D 471/14, C07D 473/34, C07D 487/04, C07D 495/04
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP13814903

AN ORAL IRON (III) BASED PHOSPHATE ADSORBENT FOR TREATING IRON-DEFICIENCY ANEMIA IN CATS WITH CHRONIC KIDNEY DISEASE

IPC classification:
A61K 33/26, A61P 7/06
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13815504

(HETERO) ARYLACRYLAMIDES FOR THE CONTROL OF ECTOPARASITES

IPC classification:
A01N 37/18, A01N 43/04, A01N 43/08, A01N 43/10, A01N 43/40
Applicant:
Novartis Tiergesundheit AG
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
EXAMINATION IN PROGRESS
EP14172659

New compounds

IPC classification:
A01N 41/06, A01N 43/36, A01N 43/40, A01N 43/54, A01N 43/78, C07C 311/08, C07D 207/335, C07D 213/643, C07D 239/34, C07D 277/66
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP14182960

ANTHRANILAMIDES, SULFONAMIDES AND NITRO ANALOGUES DERIVED THEREFROM AS ANTHELMINTICS

IPC classification:
A61K 31/18, A61P 33/10, C07C 205/11, C07C 311/08, C07C 311/20, C07D 213/61
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Eli Lilly and Company Limited
Status:
APPLICATION REFUSED
EP12704256

ISOXAZOLINE DERIVATIVES FOR CONTROLLING INVERTEBRATE PESTS

IPC classification:
A01N 43/84, A01N 47/24
Applicant:
Novartis AG
Applicant:
Novartis Tiergesundheit AG
Agent:
Bernd Liphardt, Novartis Animal Health Inc
Agent:
Multiple attorneys, Eli Lilly and Company Limited
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature